Information Provided By:
Fly News Breaks for February 22, 2019
ATR
Feb 22, 2019 | 08:48 EDT
Vertical Research downgraded AptarGroup to Sell from Hold following the Q4 report saying valuation more than reflects pharma's "magic" as cash flow yield "plummets."